Sir David Baulcombe | |
---|---|
Born | David Charles Baulcombe 7 April 1952 [1] [2] Solihull, England |
Nationality | British |
Alma mater |
|
Known for | |
Spouse | Rose Eden (m. 1976) [3] [2] |
Children | 1 son, 3 daughters [3] [2] |
Awards |
|
Scientific career | |
Fields | |
Institutions | |
Thesis | The Processing and Intracellular Transport of Messenger RNA in a Higher Plant (1976) |
Doctoral advisor | John Ingle |
Doctoral students | |
Website |
Sir David Charles Baulcombe FRS FMedSci [4] (born 7 April 1952 [1] [2] ) is a British plant scientist and geneticist. As of October 2024 [update] he was Head of Group, Gene Expression, in the Department of Plant Sciences at the University of Cambridge, and the Edward Penley Abraham Royal Society Research Professor and Regius Professor of Botany Emeritus at Cambridge. [7] He held the Regius botany chair in that department from 2007 to 2020. [8] [ third-party source needed ]
This section needs expansionwith: clear source-derived, independent (non-self-published) biographical content relevant to the section title. You can help by adding to it. (October 2024) |
David Baulcombe was born on 7 April 1952 in the United Kingdom, in Solihull, Warwickshire, [1] [8] (in England's Midlands), into "a non-scientific family". [9]
He received his Bachelor of Science degree in botany from the University of Leeds in 1973, [9] at the age of 21,[ citation needed ] and continued his studies at the University of Edinburgh, receiving his Doctor of Philosophy degree in 1976/1977 [9] [10] (for research on Messenger RNA in vascular plants supervised by John Ingle[ citation needed ]).
After his PhD, Baulcombe spent the next three years as a postdoctoral fellow in North America,[ citation needed ] in Montreal, Quebec, Canada and then in Athens, Georgia, in the United States [9] (respectively, at McGill University from January 1977-November 1978, and then the University of Georgia thereafter, until December 1980[ citation needed ]). Baulcombe returned to the United Kingdom then, where he was given the opportnity to create his own research group at the Plant Breeding Institute in Cambridge [9] (PBI, the John Innes Centre [ citation needed ]). At the PBI, Baulcombe initially held the position of Higher Scientific Officer, and was promoted to Principal Scientific Officer in April 1986. [3] [ self-published source? ]
In August 1988 Baulcombe left Cambridge for Norwich.[ citation needed ] He joined the Sainsbury Laboratory in Norwich in 1988, and as of 2007 was a senior research scientist, [9] and also served as head of laboratory between 1990 and 1993 and between 1999 and 2003.[ citation needed ] In 1998 he was appointed honorary professor at the University of East Anglia, and given a full professorship there in 2002. [3] [ self-published source? ] In March 2007 it was announced that Baulcombe would become the next Professor of Botany at the University of Cambridge (as a Royal Society Research Professor[ citation needed ]), taking up his post in September 2007. [11] Accordingly, in 2008, Baulcombe was also named as a Fellow of Trinity College, Cambridge.[ citation needed ] In 2009, the Cambridge professorship was renamed "Regius Professor of Botany". [12] He was succeeded in the chair by Ottoline Leyser in 2020. [13]
Baulcombe "serves on several [professional] committees and study sections", [8] [ third-party source needed ]and was president of the International Society of Plant Molecular Biology from 2003–2004.[ citation needed ] In the approximate period of 2007-2009, Baulcombe was a Senior Advisor to The EMBO Journal . [14] He also served on the Life Sciences jury for the Infosys Prize in 2015.[ citation needed ]
An annotation regarding Baulcombe's 2001 nomination to The Royal Society read that he had
made an outstanding contribution to the inter-related areas of plant virology, gene silencing and disease resistance... discover[ing] a specific signalling system and an antiviral defence system in plants... [leading] to the development of new technologies that promise to revolutionise gene discovery in plant biology. [15] [ better source needed ][ verification needed ]
Hence, his research interests have mainly been in botany and fundamental biology, in the fields of virus movement, genetic regulation, disease resistance, and RNA and more generally, gene silencing.[ according to whom? ] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [ third-party source needed ]
In 1998 Craig Mello, Andrew Fire, and colleagues reported a potent gene silencing effect—observations on the mechanism of RNA interference—after injecting double stranded RNA into Caenorhabditis elegans , [28] [29] a discovery notable as a detailed description of what proved to be the correct mechanism of a broad class of phenomena. [28] Baulcombe then, with Andrew Hamilton, discovered a small interfering RNA that is the specificity determinant in RNA-mediated gene silencing in plants. [30] [ third-party source needed ] Baulcombe's group demonstrated "that while viruses can induce gene silencing some viruses encode proteins that suppress gene silencing". [8] [ third-party source needed ] After these initial observations, many laboratories around the world searched for the occurrence of this phenomenon in other organisms.[ citation needed ] (The leaders of the team reporting the correct mechanism of the phenomena, Fire and Mello, were awarded the Nobel Prize in Physiology or Medicine in 2006 for their work, [28] although some have argued that Baulcombe was among those overlooked for that year's prize. [31] )
With other members of his research group at the Sainsbury Laboratory, Baulcombe also helped unravel the importance of small interfering RNA in epigenetics and in defence against viruses.[ citation needed ]
This section needs additional citations for verification .(October 2024) |
In June 2009, Baulcombe was knighted by Queen Elizabeth II in the 2009 Birthday Honours List, "for services to plant science". [32]
Baulcombe has also received the following honours and awards:
Baulcombe stated in a post dated 2017 that outside of the laboratory, he "promote[s] the use of plant biotechnology for crop improvement... [and that he is] particularly interested in technologies addressing problems in developing countries." [33] He has said he works on plants "because their products are good to eat and wear and write on—and also because plants are often good models for general biology. [14]
As of this date,[ when? ] Baulcombe resided in Norwich.[ citation needed ] He has been married to Rose Eden since 1976, and they have four children. [3] [2] His interests include music, sailing, and hill walking. [3]
This month, in-cites correspondent Gary Taubes talks with Professor David Baulcombe of the John Innes Centre's Sainsbury Laboratory about his highly cited paper, "A species of small antisense RNA in posttranscriptional gene silencing in plants," (Hamilton AJ, Baulcombe DC, Science 286[5441]: 950-2, 1999). This paper is currently ranked at #5 among Plant & Animal Science papers published in the past decade, with 747 citations... .
{{cite web}}
: CS1 maint: multiple names: authors list (link)Ribonucleic acid (RNA) is a polymeric molecule that is essential for most biological functions, either by performing the function itself or by forming a template for the production of proteins. RNA and deoxyribonucleic acid (DNA) are nucleic acids. The nucleic acids constitute one of the four major macromolecules essential for all known forms of life. RNA is assembled as a chain of nucleotides. Cellular organisms use messenger RNA (mRNA) to convey genetic information that directs synthesis of specific proteins. Many viruses encode their genetic information using an RNA genome.
Gene silencing is the regulation of gene expression in a cell to prevent the expression of a certain gene. Gene silencing can occur during either transcription or translation and is often used in research. In particular, methods used to silence genes are being increasingly used to produce therapeutics to combat cancer and other diseases, such as infectious diseases and neurodegenerative disorders.
The Department of Plant Sciences is a department of the University of Cambridge that conducts research and teaching in plant sciences. It was established in 1904, although the university has had a professor of botany since 1724.
Sir Gregory Paul Winter is a Nobel Prize-winning English molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering, in Cambridge, England.
Craig Cameron Mello is an American biologist and professor of molecular medicine at the University of Massachusetts Medical School in Worcester, Massachusetts. He was awarded the 2006 Nobel Prize for Physiology or Medicine, along with Andrew Z. Fire, for the discovery of RNA interference. This research was conducted at the Carnegie Institution of Washington and published in 1998. Mello has been a Howard Hughes Medical Institute investigator since 2000.
Andrew Zachary Fire is an American biologist and professor of pathology and of genetics at the Stanford University School of Medicine. He was awarded the 2006 Nobel Prize in Physiology or Medicine, along with Craig C. Mello, for the discovery of RNA interference (RNAi). This research was conducted at the Carnegie Institution of Washington and published in 1998.
RNA silencing or RNA interference refers to a family of gene silencing effects by which gene expression is negatively regulated by non-coding RNAs such as microRNAs. RNA silencing may also be defined as sequence-specific regulation of gene expression triggered by double-stranded RNA (dsRNA). RNA silencing mechanisms are conserved among most eukaryotes. The most common and well-studied example is RNA interference (RNAi), in which endogenously expressed microRNA (miRNA) or exogenously derived small interfering RNA (siRNA) induces the degradation of complementary messenger RNA. Other classes of small RNA have been identified, including piwi-interacting RNA (piRNA) and its subspecies repeat associated small interfering RNA (rasiRNA).
Thomas Tuschl is a German biochemist and molecular biologist, known for his research on RNA.
Victor R. Ambros is an American developmental biologist and Nobel Laureate who discovered the first known microRNA (miRNA). He is a professor at the University of Massachusetts Medical School. He completed both his undergraduate and doctoral studies at the Massachusetts Institute of Technology. Ambros received the Nobel Prize in Physiology or Medicine in 2024 for his research on microRNA.
Gary Bruce Ruvkun is an American molecular biologist and Nobel laureate at Massachusetts General Hospital and professor of genetics at Harvard Medical School in Boston.
Dame Caroline Dean is a British plant scientist working at the John Innes Centre. She is focused on understanding the molecular controls used by plants to seasonally judge when to flower. She is specifically interested in vernalisation — the acceleration of flowering in plants by exposure to periods of prolonged cold. She has also been on the Life Sciences jury for the Infosys Prize from 2018.
RNA interference (RNAi) is a biological process in which RNA molecules are involved in sequence-specific suppression of gene expression by double-stranded RNA, through translational or transcriptional repression. Historically, RNAi was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. The detailed study of each of these seemingly different processes elucidated that the identity of these phenomena were all actually RNAi. Andrew Fire and Craig C. Mello shared the 2006 Nobel Prize in Physiology or Medicine for their work on RNAi in the nematode worm Caenorhabditis elegans, which they published in 1998. Since the discovery of RNAi and its regulatory potentials, it has become evident that RNAi has immense potential in suppression of desired genes. RNAi is now known as precise, efficient, stable and better than antisense therapy for gene suppression. Antisense RNA produced intracellularly by an expression vector may be developed and find utility as novel therapeutic agents.
The Massry Prize was established in 1996, and is administered by the Meira and Shaul G. Massry Foundation. The Prize, of $40,000 and the Massry Lectureship, is bestowed upon scientists who have made substantial recent contributions in the biomedical sciences. Shaul G. Massry, M.D., who established the Massry Foundation, is Professor Emeritus of Medicine and Physiology and Biophysics at the Keck School of Medicine, University of Southern California. He served as Chief of its Division of Nephrology from 1974 to 2000. In 2009 the KECK School of Medicine was asked to administer the Prize, and has done so since that time. Out of 25 prizes bestowed until 2021, fourteen were awarded to future Nobel Prize winners. No Massry Prize was awarded in 2020, 2022 and 2023.
Julie Ann Ahringer is an American/British Professor of Genetics and Genomics, Director of the Gurdon Institute and a member of the Department of Genetics at the University of Cambridge. She leads a research lab investigating the control of gene expression.
Michael Webster Bevan is a professor at the John Innes Centre, Norwich, UK.
Dame Amanda Gay Fisher is a British cell biologist and Director of the Medical Research Council (MRC) London Institute of Medical Sciences at the Hammersmith Hospital campus of Imperial College London, where she is also a Professor leading the Institute of Clinical Sciences. She has made contributions to multiple areas of cell biology, including determining the function of several genes in HIV and describing the importance of a gene's location within the cell nucleus.
Robert Anthony Martienssen is a British plant biologist, Howard Hughes Medical Institute–Gordon and Betty Moore Foundation investigator, and professor at Cold Spring Harbor Laboratory, US.
Sir Hugh Reginald Brentnall Pelham, is a cell biologist who has contributed to our understanding of the body's response to rises in temperature through the synthesis of heat shock proteins. He served as director of the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) between 2006 and 2018.
Sir Richard Henry Treisman is a British scientist specialising in the molecular biology of cancer. Treisman is a director of research at the Francis Crick Institute in London.
Rosalind 'Candy' Lee is a biomedical scientist, best known for her breakthrough paper on the discovery of microRNA which was published in 1993. In 2002, Lee was joint receipient of the Newcomb Cleveland Prize, for the best paper published in the journal Science that year. In 2024, Lee's 1993 paper was cited as the seminal discovery for which the Nobel Prize in physiology or medicine was awarded that year, to co-author Victor Ambros.
David Charles Baulcombe was born in Solihull, Warwickshire, United Kingdom in 1952. He received his B.S. degree in botany from the University of Leeds and his Ph.D. from the University of Edinburgh. Since 1988, Dr. Baulcombe has been at the Sainsbury Laboratory Norwich, U.K. ... Dr. Baulcombe also has demonstrated that while viruses can induce gene silencing some viruses encode proteins that suppress gene silencing. Dr. Baulcombe is internationally renowned for his research and serves on several committees and study sections. In 2001, Dr. Baulcombe was elected a fellow of the Royal Society.
David Baulcombe was born in the Midlands of the UK into a non-scientific family. He studied botany as an undergraduate at Leeds University (BSc 1973) and started his own research group at the Plant Breeding Institute in Cambridge after his PhD in Edinburgh (1977) and spells as a postdoc in Montreal and Athens Georgia. He has been in the Sainsbury Laboratory in Norwich since 1988 where he is a senior research scientist. His research interests have spanned plant hormones, root nodule symbioses, disease resistance, virology and over the last ten years have focused on RNA silencing and epigenetics. David has served as President of the International Society of Plant Molecular Biology and his research has been recognised by various awards, including elections to the Royal Society and the US National Academy of Sciences (foreign associate). His current interests include a systems approach to understanding the role of short silencing RNA in regulatory networks.
The Department is pleased to announce the election of Professor David Baulcombe FRS, as the new Professor of Botany with effect from 1 September 2007. Professor Baulcombe, is currently a Senior Research Scientist at the Sainsbury Laboratory, John Innes Centre in Norwich. Trained as a botanist, his research interests are in the area of plant gene expression generally. As a result of his studies of expressing viral genes in plants, he established the role of small RNAs in RNA silencing, a mechanism for regulation of gene expression that is universal (see an interview). Professor Baulcombe has been the recipient of numerous prizes and awards in recognition of his work, including the Massry Prize from the Massry Foundation, University of Southern California in 2005 and the Wiley Prize in Biomedical Science from the Wiley Foundation, Rockefeller University, both shared with Craig Mello and Andrew Fire. He was elected to the Royal Society in 2001, and as a foreign associate member of the National Academy of Sciences (USA) in 2005.
David Baulcombe is in The Sainsbury Laboratory in Norwich. His lab works on viruses, disease resistance and gene silencing using a combination of genetic, molecular and biological approaches. David works on plants because their products are good to eat and wear and write on - and also because plants are often good models for general biology.
David Baulcombe has made an outstanding contribution to the inter-related areas of plant virology, gene silencing and disease resistance. He discovered a specific signalling system and an antiviral defence system in plants. This led to the development of new technologies that promise to revolutionize gene discovery in plant biology.. This citation purports to be an archived result of a search of a Royal Society database, from the Repository, "GB 117", providing "EC/2001/03" as a reference number (Ref No). A Google Advanced Search of the quoted material returns no leads on the web. Search of the URL and other content fields at Web.Archive.org also fails.
Andrew Fire and Craig Mello published their break-through study on the mechanism of RNA interference in Nature in 1998...
...many felt the scientists who did the research that helped lead to Fire and Mello's discovery--Ambros... and Ruvkun... working with worms and Baulcombe..., plants...--deserved a place in Nobel history as well... Nobel committees rarely revisit research areas for which they've already handed out prizes. In 2008, though, Ambros, Ruvkun and Baulcombe started racking up prestigious honors, such as the Franklin Medal and the Lasker Award, suggesting they might still have a shot at sharing their own Nobel some day.
University of Cambridge—United Kingdom—EMBO 1997—Disease resistance, RNA and epigenetics in plants—Much of my current research follows from the discovery in my Norwich laboratory of a novel type of regulatory RNA – siRNA. Current projects in the laboratory focus on the mechanisms of siRNA-mediated regulation and their influence on natural variation. Outside the laboratory I promote the use of plant biotechnology for crop improvement. I am particularly interested in technologies addressing problems in developing countries.
David Baulcombe / Membership Number: 2159 / Membership type: Ordinary / Section: Cell & Developmental Biology / Elected: 2002.
The 2nd annual Wiley Prize in the Biomedical Sciences was awarded to Andrew Z. Fire, Craig C. Mello, Thomas Tuschl, and David Baulcombe for their respective contributions to discoveries of novel mechanisms for regulating gene expression by small interfering RNAs (siRNA).
{{cite web}}
: CS1 maint: url-status (link)DavidBaulcombe / Year—2008 / Subject—Life Science / Award—Benjamin Franklin Medal / Affiliation—University of Cambridge... / Citation—With Gary Ruvkun and Victor Ambros, for their discovery of small RNAs that turn off genes. Their pioneering work initiated a paradigm shift in our perception of the ways genes are regulated, and this insight is making possible major new genetic tools for basic research, and for improving agriculture and human health.. See also this archive of an earlier web post, archive date 15 May 2008.
2008 Benjamin Franklin medal in life science is Presented to Victor Ambros, Ph.D. (University of Massachusetts Medical School, Worcester, Massachusetts), Gary Ruvkun, Ph.D. (Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts) and David Baulcombe, Ph.D., FRS (University of Cambridge, Cambridge, UK).
The Maize Genetics Executive Committee would like to announce that the winner of the inaugural McClintock Prize for Plant Genetics and Genome Studies is Prof. Sir David Baulcombe of the University of Cambridge. This award is in recognition of his exceptional contributions in the field of plant epigenetics, a field in which Dr. McClintock was one of the pioneers.